ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,256,000 | -8.4% | 1,046,700 | 0.0% | 0.04% | 0.0% |
| Q1 2022 | $1,371,000 | -25.6% | 1,046,700 | 0.0% | 0.04% | -27.1% |
| Q4 2021 | $1,842,000 | -33.9% | 1,046,700 | +37.2% | 0.06% | -84.1% |
| Q3 2017 | $2,785,000 | +27.4% | 762,947 | -12.8% | 0.37% | -4.4% |
| Q2 2017 | $2,186,000 | -7.4% | 874,447 | 0.0% | 0.39% | -35.0% |
| Q1 2017 | $2,361,000 | -6.9% | 874,447 | 0.0% | 0.60% | -26.0% |
| Q4 2016 | $2,536,000 | -34.8% | 874,447 | -7.6% | 0.81% | -32.4% |
| Q3 2016 | $3,889,000 | – | 946,263 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |